Page last updated: 2024-10-15

alpha-(4-pyridyl-1-oxide)-n-tert-butylnitrone

Description

alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135532295
MeSH IDM0127849

Synonyms (24)

Synonym
alpha-(4-pyridyl-1-oxide)-n-tert-butylnitrone
tert-butyl-[(1-oxidopyridin-4-ylidene)methyl]-oxoazanium
2140sm8q5o ,
2-propanamine, 2-methyl-n-(4-pyridinylmethylene)-, n,n'-dioxide
pyridyloxide tert-butylnitrone
.alpha.-(4-pyridyl-1-oxide)-n-tert-butylnitrone
c-(4-pyridinyl-n-oxide)-n-tert-butylnitrone
.alpha.-(4-pyridyl-1-oxide)-n-t-butylnitrone
2-propanamine, 2-methyl-n-((1-oxido-4-pyridinyl)methylene)-, n-oxide
n-tert-butyl-.alpha.-(4-pyridyl-1-oxide) nitrone
n-tert-butyl-'a-(4-pyridl)nitrone n'-oxide
pyridyloxide t-butylnitrone [inci]
(z)-2-methyl-n-((1-oxidopyridin-4-yl)methylene)propan-2-amine oxide
DTXSID60217036
AKOS025394798
alpha-(4-pyridyl-n-oxide)-n-t-butylnitrone
tert-butyl-[(1-oxidanidylpyridin-4-ylidene)methyl]-oxidanylidene-azanium
Q27253513
n-tert-butyl-1-(1-oxidopyridin-1-ium-4-yl)methanimine oxide
alpha-(4-pyridyl 1-oxide)-n-tert-butylnitrone
AS-55806
AKOS037644986
HY-114713
CS-0064148

Toxicity

ExcerptReference
"Polyunsaturated fatty acids such as arachidonic acid were previously shown to be toxic to HepG2 cells expressing CYP2E1 by a mechanism involving oxidative stress and lipid peroxidation."( Spin trapping agents (Tempol and POBN) protect HepG2 cells overexpressing CYP2E1 against arachidonic acid toxicity.
Cederbaum, AI; PĂ©rez, MJ, 2001
)
"Amiodarone (AM), an antidysrrhythmic drug, can produce serious adverse effects, including potentially fatal AM-induced pulmonary toxicity (AIPT)."( Aryl radical involvement in amiodarone-induced pulmonary toxicity: investigation of protection by spin-trapping nitrones.
Bedard, LL; Brien, JF; Comeau, JL; Hill, BC; Massey, TE; Nicolescu, AC; Racz, WJ; Takahashi, T, 2007
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (129)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (8.53)18.7374
1990's70 (54.26)18.2507
2000's39 (30.23)29.6817
2010's8 (6.20)24.3611
2020's1 (0.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other130 (98.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]